Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 10, 2011, Pages 4712-4717

  Akbergenov, Rashid ^a   Shcherbakov, Dmitri ^a   Matt, Tanja ^a   Duscha, Stefan ^a   Meyer, Martin ^a   Wilson, Daniel N ^b   Böttger, Erik C ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPREOMYCIN; VIOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; MYCOBACTERIUM SMEGMATIS; NONHUMAN; OTOTOXICITY; PHYLOGENY; PRIORITY JOURNAL; RIBOSOME; RNA ANALYSIS; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

AMINOGLYCOSIDES; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CAPREOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENVIOMYCIN; MUTAGENESIS, SITE-DIRECTED; MYCOBACTERIUM TUBERCULOSIS; RIBOSOMES; RNA, RIBOSOMAL, 16S; RNA, RIBOSOMAL, 23S; VIOMYCIN;

EID: 80052837389     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00628-11     Document Type: Article

References (39)

1. Blumberg, H. M. et al. 2003. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am. J. Respir. Crit. Care Med. 167:603-662.
2. Böttger, E. C. 2007. Antimicrobial agents targeting the ribosome: the issue of selectivity and toxicity - lessons to be learned. Cell. Mol. Life Sci. 64:791-795.
3. Böttger, E. C., B. Springer, T. Prammananan, Y. Kidan, and P. P. Sander. 2001. Structural basis for selectivity and toxicity of ribosomal antibiotics. EMBO Rep. 2:318-323.
4. Böttger, E. C., and B. Springer. 2008. Tuberculosis: drug resistance, fitness, and strategies for global control. Eur. J. Pediatr. 167:141-148.
5. Böttger, E. C., B. Springer, M. Pletschette, and P. Sander. 1998. Fitness of antibiotic-resistant microorganisms and compensatory mutations. Nat. Med. 4:1343-1344.
6. Bruell, C. M. et al. 2008. Conservation of bacterial protein synthesis machinery: initiation and elongation in Mycobacterium smegmatis. Biochemistry 47:8828-8839.
7. Bryskier, A. 2005. Antimicrobial agents: antibacterials and antifungals. ASM Press, Washington, DC.
8. Choi, E. C. et al. 1979. Viomycin resistance: alterations of either ribosomal subunit affect the binding of the antibiotic to the pair subunit and the entire ribosome becomes resistant to the drug. Biochem. Biophys. Res. Commun. 87:904-910.
9. Davies, J., L. Gorini, and B. D. Davis. 1965. Misreading of RNA codewords induced by aminoglycoside antibiotics. Mol. Pharmacol. 1:93-106.
10. Dye, C., M. A. Espinal, C. J. Watt, C. Mbiaga, and B. G. Williams. 2002. Worldwide incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 185:1197-1202.
11. Ermolenko, D. N. et al. 2007. The antibiotic viomycin traps the ribosome in an intermediate state of translocation. Nat. Struct. Mol. Biol. 14:493-497.
12. Farmer, P., and J. Y. Kim. 1998. Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus." BMJ 317:671-674.
13. Feuerriegel, S. et al. 2009. Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrob. Agents Chemother. 53:3353-3356.
14. Hobbie, S. N. et al. 2008. Mitochondrial deafness alleles confer misreading of the genetic code. Proc. Natl. Acad. Sci. U. S. A. 105:3244-3249.
15. Hobbie, S. N. et al. 2007. Engineering the rRNA decoding site of eukaryotic cytosolic ribosomes in bacteria. Nucleic Acids Res. 35:6086-6093. (Pubitemid 350018572)
16. Hobbie, S. N. et al. 2008. Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity. Proc. Natl. Acad. Sci. U. S. A. 105:20888-20893.
17. Johansen, S. K., C. E. Maus, B. B. Plikaytis, and S. Douthwaite. 2006. Capreomycin binds across the ribosomal subunit interface using tlyA-encoded 2′-O-methylations in 16S and 23S rRNAs. Mol. Cell 23:173-182.
18. Jugheli, L. et al. 2009. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrob. Agents Chemother. 53:5064-5068.
19. Marrero, P., M. J. Cabanas, and J. Modolell. 1980. Induction of translational errors (misreading) by tuberactinomycins and capreomycins. Biochem. Biophys. Res. Commun. 97:1047-1052.
20. Maus, C. E., B. B. Plikaytis, and T. M. Shinnick. 2005. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:3192-3197.
21. Maus, C. E., B. B. Plikaytis, and T. M. Shinnick. 2005. Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 49:571-577.
22. McClatchy, J. K., W. Kanes, P. T. Davidson, and T. S. Moulding. 1977. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin. Tubercle 58:29-34.
23. McKee, E. E., M. Ferguson, A. T. Bentley, and T. A. Marks. 2006. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob. Agents Chemother. 50:2042-2049.
24. Modolell, J., and D. Vazquez. 1977. The inhibition of ribosomal translocation by viomycin. Eur. J. Biochem. 81:491-497.
25. Monshupanee, T., S. T. Gregory, S. Douthwaite, W. Chungjatupornchai, and A. E. Dahlberg. 2008. Mutations in conserved helix 69 of 23S rRNA of Thermus thermophilus that affect capreomycin resistance but not posttranscriptional modifications. J. Bacteriol. 190:7754-7761.
26. Peske, F., A. Savelsbergh, V. I. Katunin, M. V. Rodnina, and W. Wintermeyer. 2004. Conformational changes of the small ribosomal subunit during elongation factor G-dependent tRNA-mRNA translocation. J. Mol. Biol. 343:1183-1194.
27. Pfister, P. et al. 2005. Mutagenesis of 16S rRNA C1409-G1491 base-pair differentiates between 6′OH and 6′NH3+ aminoglycosides. J. Mol. Biol. 346:467-475.
28. Prammananan, T., P. Sander, B. Springer, and E. C. Böttger. 1999. RecA-mediated gene conversion and aminoglycoside resistance in strains heterozygous for rRNA. Antimicrob. Agents Chemother. 43:447-453.
29. Prezant, T. R. et al. 1993. Mitochondrial rRNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat. Genet. 4:289-294.
30. Salas-Marco, J., and D. M. Bedwell. 2005. Discrimination between defects in elongation fidelity and termination efficiency provides mechanistic insights into translational readthrough. J. Mol. Biol. 348:801-815.
31. Sander, P. et al. 2002. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother. 46:1204-1211.
32. Shcherbakov, D. et al. 2010. Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in-vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis. Mol. Microbiol. 77:830-840.
33. Springer, B., K. Lucke, R. Calligaris-Maibach, C. Ritter, and E. C. Böttger. 2009. Quantitative drug susceptibility testing of Mycobacterium tuberculosis by use of MGIT 960 and EpiCenter instrumentation. J. Clin. Microbiol. 47:1773-1780.
34. Stanley, R. E., G. Blaha, R. L. Grodzicki, M. D. Strickler, and T. A. Steitz. 2010. The structures of the anti-tuberculosis antibiotics viomycin and capreomycin bound to the 70S ribosome. Nat. Struct. Mol. Biol. 17:289-293.
35. Sutton, W. B., R. S. Gordee, W. E. Wick, and L. Stanfield. 1966. In vitro and in vivo laboratory studies on the antituberculous activity of capreomycin. Ann. N. Y. Acad. Sci. 135:947-959.
36. Tsukamura, M. 1969. Cross-resistance relationships between capreomycin, kanamycin, and viomycin resistances in tubercle bacilli from patients. Am. Rev. Respir. Dis. 99:780-782.
37. Yamada, T., Y. Mizugichi, K. H. Nierhaus, and H. G. Wittmann. 1978. Resistance to viomycin conferred by RNA of either ribosomal subunit. Nature 275:460-461.
38. Yunis, A. A. 1989. Chloramphenicol toxicity: 25 years of research. Am. J. Med. 87:44N-48N.
39. Zhao, H. et al. 2004. Maternally inherited aminoglycoside-induced and non-syndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am. J. Hum. Genet. 74:139-152.